Cargando…

Oncogenic activity of SOX1 in glioblastoma

Glioblastoma remains the most common and deadliest type of brain tumor and contains a population of self-renewing, highly tumorigenic glioma stem cells (GSCs), which contributes to tumor initiation and treatment resistance. Developmental programs participating in tissue development and homeostasis r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia, Idoia, Aldaregia, Juncal, Marjanovic Vicentic, Jelena, Aldaz, Paula, Moreno-Cugnon, Leire, Torres-Bayona, Sergio, Carrasco-Garcia, Estefania, Garros-Regulez, Laura, Egaña, Larraitz, Rubio, Angel, Pollard, Steven, Stevanovic, Milena, Sampron, Nicolas, Matheu, Ander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397861/ https://www.ncbi.nlm.nih.gov/pubmed/28425506 http://dx.doi.org/10.1038/srep46575

Ejemplares similares

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2016)

mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019)

Targeting mTOR as a Therapeutic Approach in Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2018)

PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2018)

Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2022)

Increased Arf/p53 activity in stem cells, aging and cancer
por: Carrasco‐Garcia, Estefania, et al.
Publicado: (2017)

SOX9 promotes tumor progression through the axis BMI1-p21(CIP)
por: Aldaz, Paula, et al.
Publicado: (2020)

High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
por: Arrizabalaga, Olatz, et al.
Publicado: (2017)

High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML
por: Aldaz, Paula, et al.
Publicado: (2022)

Erbb4 Is Required for Cerebellar Development and Malignant Phenotype of Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2020)

SOX2 haploinsufficiency promotes impaired vision at advanced age
por: Moreno-Cugnon, Leire, et al.
Publicado: (2018)

Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
por: Egaña, Larraitz, et al.
Publicado: (2020)

Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma
por: Aldaz, Paula, et al.
Publicado: (2021)

Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2020)

Elevated p38MAPK activity promotes neural stem cell aging
por: Moreno-Cugnon, Leire, et al.
Publicado: (2020)

SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2022)

Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer
por: Otaegi-Ugartemendia, Maddalen, et al.
Publicado: (2022)

Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2022)

Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2023)

Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2018)

CD8(+) T cells are increased in the subventricular zone with physiological and pathological aging
por: Moreno‐Valladares, Manuel, et al.
Publicado: (2020)

CD8(+) T cells are present at low levels in the white matter with physiological and pathological aging
por: Moreno-Valladares, Manuel, et al.
Publicado: (2020)

In vitro P38MAPK inhibition in aged astrocytes decreases reactive astrocytes, inflammation and increases nutritive capacity after oxygen-glucose deprivation
por: Revuelta, Miren, et al.
Publicado: (2021)

Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2015)

CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2021)

Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models
por: Álvarez-Satta, María, et al.
Publicado: (2020)

Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
por: Alonso, Marta M., et al.
Publicado: (2011)

SOX2 is required independently in both stem and differentiated cells for pituitary tumorigenesis in p27-null mice
por: Moncho-Amor, Veronica, et al.
Publicado: (2021)

Reciprocal Repression between Sox3 and Snail Transcription Factors Defines Embryonic Territories at Gastrulation
por: Acloque, Hervé, et al.
Publicado: (2011)

Neuronal p38α mediates age‐associated neural stem cell exhaustion and cognitive decline
por: Moreno‐Cugnon, Leire, et al.
Publicado: (2019)

Evidence That SOX2 Overexpression Is Oncogenic in the Lung
por: Lu, Yun, et al.
Publicado: (2010)

SIX1 represses senescence and promotes SOX2-mediated cellular plasticity during tumorigenesis
por: De Lope, Cristina, et al.
Publicado: (2019)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

p27(Kip1) Directly Represses Sox2 during Embryonic Stem Cell Differentiation
por: Li, Han, et al.
Publicado: (2012)

Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation
por: Alberro, Ainhoa, et al.
Publicado: (2016)

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
por: Stolzenburg, Sabine, et al.
Publicado: (2012)

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2019)

Targeting oncogenic SOX2 in human cancer cells: therapeutic application
por: Zhang, Shizhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2o7jfprobbm28cs2mvh9f07ifl